Literature DB >> 9576545

Apathy and hypersomnia are common features of myotonic dystrophy.

J S Rubinsztein1, D C Rubinsztein, S Goodburn, A J Holland.   

Abstract

OBJECTIVES: Myotonic dystrophy is a disease characterised by myotonia and muscle weakness. Psychiatric disorder and sleep problems have also been considered important features of the illness. This study investigated the extent to which apathy, major depression, and hypersomnolence were present. The objective was to clarify if the apathy reported anecdotally was a feature of CNS involvement or if this was attributable to major depression, hypersomnolence, or a consequence of chronic muscle weakness.
METHODS: These features were studied in 36 adults with non-congenital myotonic dystrophy and 13 patients with Charcot-Marie-Tooth disease. By using patients with Charcot-Marie-Tooth disease as a comparison group the aim was to control for the disabling effects of having an inherited chronic neurological disease causing muscle weakness. Standardised assessment instruments were used wherever possible to facilitate comparison with other groups reported in the medical literature.
RESULTS: There was no excess of major depression on cross sectional analysis in these patients with mild myotonic dystrophy. However, apathy was a prominent feature of myotonic dystrophy in comparison with a similarly disabled group of patients with Charcot-Marie-Tooth disease (clinician rated score; Mann Whitney U test, p=0.0005). Rates of hypersomnolence were greater in the myotonic dystrophy group, occurring in 39% of myotonic dystrophy patients, but there was no correlation with apathy.
CONCLUSION: These data suggest that apathy and hypersomnia are independent and common features of myotonic dystrophy. Apathy cannot be accounted for by clinical depression or peripheral muscle weakness and is therefore likely to reflect CNS involvement. These features of the disease impair quality of life and may be treatable.

Entities:  

Mesh:

Year:  1998        PMID: 9576545      PMCID: PMC2170039          DOI: 10.1136/jnnp.64.4.510

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  38 in total

1.  Central nervous system magnetic resonance imaging findings in myotonic dystrophy.

Authors:  R H Glantz; R B Wright; M S Huckman; D C Garron; I M Siegel
Journal:  Arch Neurol       Date:  1988-01

2.  Fatigue syndromes: a comparison of chronic "postviral" fatigue with neuromuscular and affective disorders.

Authors:  S Wessely; R Powell
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-08       Impact factor: 10.154

3.  Neuropathological changes of the brain in myotonic dystrophy--some new observations.

Authors:  S Ono; K Inoue; T Mannen; F Kanda; K Jinnai; K Takahashi
Journal:  J Neurol Sci       Date:  1987-11       Impact factor: 3.181

Review 4.  Disorders of excessive sleepiness.

Authors:  C Guilleminault
Journal:  Ann Clin Res       Date:  1985

5.  Neuropsychological profile in myotonic dystrophy.

Authors:  B Censori; M Danni; M Del Pesce; L Provinciali
Journal:  J Neurol       Date:  1990-07       Impact factor: 4.849

6.  Magnetic resonance imaging and clinical correlates of intellectual impairment in myotonic dystrophy.

Authors:  S J Huber; J T Kissel; E C Shuttleworth; D W Chakeres; L E Clapp; M A Brogan
Journal:  Arch Neurol       Date:  1989-05

7.  Neuropsychological findings in myotonic dystrophy.

Authors:  J B Woodward; R K Heaton; D B Simon; S P Ringel
Journal:  J Clin Neuropsychol       Date:  1982-12

8.  Computed tomographic findings of brain and skull in myotonic dystrophy.

Authors:  E Avrahami; A Katz; N Bornstein; A D Korczyn
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-04       Impact factor: 10.154

9.  Cognitive and personality function in myotonic muscular dystrophy.

Authors:  T D Bird; C Follett; E Griep
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-11       Impact factor: 10.154

10.  Myotonic dystrophy as a disease of abnormal membrane receptors: an hypothesis of pathophysiology and a new approach to treatment.

Authors:  R A Brumback; K M Carlson; H Wilson; R D Staton
Journal:  Med Hypotheses       Date:  1981-08       Impact factor: 1.538

View more
  29 in total

Review 1.  Are the available apathy measures reliable and valid? A review of the psychometric evidence.

Authors:  Diana E Clarke; Jean Y Ko; Emily A Kuhl; Robert van Reekum; Rocio Salvador; Robert S Marin
Journal:  J Psychosom Res       Date:  2010-03-31       Impact factor: 3.006

2.  Daytime sleepiness and REM sleep characteristics in myotonic dystrophy: a case-control study.

Authors:  Huan Yu; Luc Laberge; Isabelle Jaussent; Sophie Bayard; Sabine Scholtz; Morales Raoul; Michel Pages; Yves Dauvilliers
Journal:  Sleep       Date:  2011-02-01       Impact factor: 5.849

3.  Towards an integrative approach to the management of myotonic dystrophy type 1.

Authors:  Cynthia Gagnon; Luc Noreau; Richard T Moxley; Luc Laberge; Stéphane Jean; Louis Richer; Michel Perron; Suzanne Veillette; Jean Mathieu
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-04-20       Impact factor: 10.154

Review 4.  Daytime sleepiness and myotonic dystrophy.

Authors:  Luc Laberge; Cynthia Gagnon; Yves Dauvilliers
Journal:  Curr Neurol Neurosci Rep       Date:  2013-04       Impact factor: 5.081

5.  Experienced fatigue in facioscapulohumeral dystrophy, myotonic dystrophy, and HMSN-I.

Authors:  J S Kalkman; M L Schillings; S P van der Werf; G W Padberg; M J Zwarts; B G M van Engelen; G Bleijenberg
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-10       Impact factor: 10.154

6.  Electrophysiological evaluation of oropharyngeal swallowing in myotonic dystrophy.

Authors:  C Ertekin; N Yüceyar; H Karasoy
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

7.  Increased EEG Theta Spectral Power in Sleep in Myotonic Dystrophy Type 1.

Authors:  Joseph Cheung; Chad Ruoff; Hyatt Moore; Katharine A Hagerman; Jennifer Perez; Sarada Sakamuri; Simon C Warby; Emmanuel Mignot; John Day; Jacinda Sampson
Journal:  J Clin Sleep Med       Date:  2018-02-15       Impact factor: 4.062

8.  Muscleblind1, but not Dmpk or Six5, contributes to a complex phenotype of muscular and motivational deficits in mouse models of myotonic dystrophy.

Authors:  Anna Matynia; Carina Hoi Ng; Warunee Dansithong; Andy Chiang; Alcino J Silva; Sita Reddy
Journal:  PLoS One       Date:  2010-03-25       Impact factor: 3.240

9.  Sleep apnea in adult myotonic dystrophy patients who have no excessive daytime sleepiness.

Authors:  Esen Kiyan; Gulfer Okumus; Caglar Cuhadaroglu; Feza Deymeer
Journal:  Sleep Breath       Date:  2009-05-30       Impact factor: 2.816

Review 10.  Congenital and childhood myotonic dystrophy: Current aspects of disease and future directions.

Authors:  Genevieve Ho; Michael Cardamone; Michelle Farrar
Journal:  World J Clin Pediatr       Date:  2015-11-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.